ITRM970418A0 - - Google Patents

Info

Publication number
ITRM970418A0
ITRM970418A0 ITRM970418A ITRM970418A ITRM970418A0 IT RM970418 A0 ITRM970418 A0 IT RM970418A0 IT RM970418 A ITRM970418 A IT RM970418A IT RM970418 A ITRM970418 A IT RM970418A IT RM970418 A0 ITRM970418 A0 IT RM970418A0
Authority
IT
Italy
Application number
ITRM970418A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT97RM000418A priority Critical patent/IT1293088B1/it
Publication of ITRM970418A0 publication Critical patent/ITRM970418A0/it
Priority to PCT/IT1998/000192 priority patent/WO1999002135A1/en
Priority to AT98932506T priority patent/ATE293958T1/de
Priority to ES98932506T priority patent/ES2242287T3/es
Priority to EP98932506A priority patent/EP1003482B1/en
Priority to DE69829975T priority patent/DE69829975T2/de
Priority to AU82409/98A priority patent/AU8240998A/en
Publication of ITRM970418A1 publication Critical patent/ITRM970418A1/it
Application granted granted Critical
Publication of IT1293088B1 publication Critical patent/IT1293088B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT97RM000418A 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in IT1293088B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
PCT/IT1998/000192 WO1999002135A1 (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules
AT98932506T ATE293958T1 (de) 1997-07-10 1998-07-09 Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle
ES98932506T ES2242287T3 (es) 1997-07-10 1998-07-09 Microparticulas para la administracion controlada de moleculas biologicamente activas.
EP98932506A EP1003482B1 (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules
DE69829975T DE69829975T2 (de) 1997-07-10 1998-07-09 Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle
AU82409/98A AU8240998A (en) 1997-07-10 1998-07-09 Microparticles for controlled delivery of biologically active molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in

Publications (3)

Publication Number Publication Date
ITRM970418A0 true ITRM970418A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-07-10
ITRM970418A1 ITRM970418A1 (it) 1999-01-10
IT1293088B1 IT1293088B1 (it) 1999-02-11

Family

ID=11405168

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000418A IT1293088B1 (it) 1997-07-10 1997-07-10 Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in

Country Status (7)

Country Link
EP (1) EP1003482B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE293958T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU8240998A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69829975T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2242287T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1293088B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999002135A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
WO2003000297A1 (fr) 2001-06-20 2003-01-03 Sumitomo Pharmaceuticals Company, Limited Procede facilitant le transfert d'acides nucleiques
JP2008067717A (ja) * 2001-06-20 2008-03-27 Dainippon Sumitomo Pharma Co Ltd 核酸導入を促進させる方法
US7166575B2 (en) 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
EA008829B1 (ru) 2002-12-17 2007-08-31 Нэстек Фармасьютикал Кампани Инк. Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения
US7186692B2 (en) 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7229966B2 (en) 2002-12-17 2007-06-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
EP3370694A1 (en) 2015-11-06 2018-09-12 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660556B1 (fr) * 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
IT1244511B (it) * 1991-04-15 1994-07-15 Isi Ist Sierovaccinogeno Ital Idrogeli a base di policarbossilati sintetici e proteine per il rilascio controllato di farmaci e procedimento per la loro preparazione.
DE69332222T3 (de) * 1992-06-11 2007-05-10 Alkermes Controlled Therapeutics, Inc., Cambridge Enythropoietin enthaltendes arzneimittelabgabesystem
WO1994023738A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression

Also Published As

Publication number Publication date
AU8240998A (en) 1999-02-08
EP1003482B1 (en) 2005-04-27
WO1999002135A1 (en) 1999-01-21
ATE293958T1 (de) 2005-05-15
DE69829975D1 (de) 2005-06-02
DE69829975T2 (de) 2006-03-09
ES2242287T3 (es) 2005-11-01
ITRM970418A1 (it) 1999-01-10
EP1003482A1 (en) 2000-05-31
IT1293088B1 (it) 1999-02-11

Similar Documents

Publication Publication Date Title
BE2018C032I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH0944937H2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970456A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITRM970418A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITBZ970019A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN186870B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE2013C047I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970346A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN188979B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITRM970146V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITPG970010V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITPD970142A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTN970005V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970330A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN192039B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN187141B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN189804B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3053525S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3058088S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3054556S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3054099S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3058984S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3058923S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3058533S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3057613S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
0001 Granted